ArticleStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2018

[Durvalumab improves prognosis of stage III non-small-cell lung cancer after definitive chemoradiotherapy].

Markus Hecht et al.PubMed ↗Publisher ↗

No numbers read from the abstract.